206 related articles for article (PubMed ID: 7592732)
1. Structural features mediating fibrin selectivity of vampire bat plasminogen activators.
Bringmann P; Gruber D; Liese A; Toschi L; Krätzchmar J; Schleuning WD; Donner P
J Biol Chem; 1995 Oct; 270(43):25596-603. PubMed ID: 7592732
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activators from the saliva of Desmodus rotundus (common vampire bat): unique fibrin specificity.
Schleuning WD; Alagon A; Boidol W; Bringmann P; Petri T; Krätzschmar J; Haendler B; Langer G; Baldus B; Witt W
Ann N Y Acad Sci; 1992 Dec; 667():395-403. PubMed ID: 1309059
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of amyloid-beta (1-42) as a cofactor for plasminogen activation by vampire bat plasminogen activator and recombinant human tissue-type plasminogen activator.
Kruithof EK; Schleuning WD
Thromb Haemost; 2004 Sep; 92(3):559-67. PubMed ID: 15351852
[TBL] [Abstract][Full Text] [Related]
4. Fibrin selectivity of the isolated protease domains of tissue-type and vampire bat salivary gland plasminogen activators.
Toschi L; Bringmann P; Petri T; Donner P; Schleuning WD
Eur J Biochem; 1998 Feb; 252(1):108-12. PubMed ID: 9523718
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E.
Stewart RJ; Fredenburgh JC; Weitz JI
J Biol Chem; 1998 Jul; 273(29):18292-9. PubMed ID: 9660794
[TBL] [Abstract][Full Text] [Related]
6. The plasminogen activator family from the salivary gland of the vampire bat Desmodus rotundus: cloning and expression.
Krätzschmar J; Haendler B; Langer G; Boidol W; Bringmann P; Alagon A; Donner P; Schleuning WD
Gene; 1991 Sep; 105(2):229-37. PubMed ID: 1937019
[TBL] [Abstract][Full Text] [Related]
7. Vampire bat salivary plasminogen activator is quiescent in human plasma in the absence of fibrin unlike human tissue plasminogen activator.
Gardell SJ; Hare TR; Bergum PW; Cuca GC; O'Neill-Palladino L; Zavodny SM
Blood; 1990 Dec; 76(12):2560-4. PubMed ID: 2124935
[TBL] [Abstract][Full Text] [Related]
8. Vampire bat salivary plasminogen activator exhibits a strict and fastidious requirement for polymeric fibrin as its cofactor, unlike human tissue-type plasminogen activator. A kinetic analysis.
Bergum PW; Gardell SJ
J Biol Chem; 1992 Sep; 267(25):17726-31. PubMed ID: 1387641
[TBL] [Abstract][Full Text] [Related]
9. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
Bakker AH; Nieuwenbroek NM; Verheijen JH
Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642
[TBL] [Abstract][Full Text] [Related]
10. Isolation, characterization, and cDNA cloning of a vampire bat salivary plasminogen activator.
Gardell SJ; Duong LT; Diehl RE; York JD; Hare TR; Register RB; Jacobs JW; Dixon RA; Friedman PA
J Biol Chem; 1989 Oct; 264(30):17947-52. PubMed ID: 2509450
[TBL] [Abstract][Full Text] [Related]
11. Catalytic domain structure of vampire bat plasminogen activator: a molecular paradigm for proteolysis without activation cleavage.
Renatus M; Stubbs MT; Huber R; Bringmann P; Donner P; Schleuning WD; Bode W
Biochemistry; 1997 Nov; 36(44):13483-93. PubMed ID: 9354616
[TBL] [Abstract][Full Text] [Related]
12. High-level secretion of the four salivary plasminogen activators from the vampire bat Desmodus rotundus by stably transfected baby hamster kidney cells.
Krätzschmar J; Haendler B; Bringmann P; Dinter H; Hess H; Donner P; Schleuning WD
Gene; 1992 Jul; 116(2):281-4. PubMed ID: 1634121
[TBL] [Abstract][Full Text] [Related]
13. Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration.
Liberatore GT; Samson A; Bladin C; Schleuning WD; Medcalf RL
Stroke; 2003 Feb; 34(2):537-43. PubMed ID: 12574572
[TBL] [Abstract][Full Text] [Related]
14. Effects of intact fibrin and partially plasmin-degraded fibrin on kinetic properties of one-chain tissue-type plasminogen activator.
Fischer BE; Will H
Biochim Biophys Acta; 1990 Oct; 1041(1):48-54. PubMed ID: 2145980
[TBL] [Abstract][Full Text] [Related]
15. The position of the structurally autonomous kringle 2 domain influences the functional features of tissue-type plasminogen activator.
Bakker AH; Rehberg EF; Marotti KR; Verheijen JH
Protein Eng; 1995 Mar; 8(3):293-300. PubMed ID: 7479691
[TBL] [Abstract][Full Text] [Related]
16. Thrombolytic properties of Desmodus rotundus (vampire bat) salivary plasminogen activator in experimental pulmonary embolism in rats.
Witt W; Baldus B; Bringmann P; Cashion L; Donner P; Schleuning WD
Blood; 1992 Mar; 79(5):1213-7. PubMed ID: 1536947
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of fibrin binding on the biochemical properties of single-chain tissue-type plasminogen activator (t-PA) and single-chain chimeric plasminogen activator (t-PA/scu-PA).
Fischer BE
Blood Coagul Fibrinolysis; 1992 Feb; 3(1):39-46. PubMed ID: 1320415
[TBL] [Abstract][Full Text] [Related]
18. Limited fibrin specificity of tissue-type plasminogen activator and its potential link to bleeding.
Weitz JI
J Vasc Interv Radiol; 1995; 6(6 Pt 2 Suppl):19S-23S. PubMed ID: 8770837
[TBL] [Abstract][Full Text] [Related]
19. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
[TBL] [Abstract][Full Text] [Related]
20. Production of vampire bat plasminogen activator DSPA alpha 1 in CHO and insect cells.
Petri T; Langer G; Bringmann P; Cashion L; Shallow S; Schleuning WD; Donner P
J Biotechnol; 1995 Feb; 39(1):75-83. PubMed ID: 7766013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]